Eplerenone and Aliskiren Research Targeting Hypertensive Patients With Left Ventricular Hypertrophy
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to determine which treatment will be more effective to
reduce left ventricular mass in hypertensive patients with left ventricular hypertrophy
comparing aliskiren and eplerenone.